News InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 Staff September 11, 2023 Iframe sync Post navigation Previous: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology TherapeuticsNext: Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors More Stories Healthcare News TempraMed Enters Strategic Media Partnership with Dr. Phil’s Envoy Media, Validating Product Portfolio and Accelerating Market Adoption Across the United States Staff February 2, 2026 Healthcare News Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth Staff February 1, 2026 Healthcare News Patient Care AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai Staff February 1, 2026
